Bellevue Group Ag Novo Nordisk A S Transaction History
Bellevue Group Ag
- $4.39 Billion
- Q2 2025
A detailed history of Bellevue Group Ag transactions in Novo Nordisk A S stock. As of the latest transaction made, Bellevue Group Ag holds 6,500 shares of NVO stock, worth $319,475. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,500Holding current value
$319,475% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding NVO
# of Institutions
1,685Shares Held
286MCall Options Held
14.8MPut Options Held
22M-
Capital International Investors Los Angeles, CA17.7MShares$871 Million0.17% of portfolio
-
Loomis Sayles & CO L P16.2MShares$795 Million1.1% of portfolio
-
Bank Of America Corp Charlotte, NC14.7MShares$724 Million0.08% of portfolio
-
Morgan Stanley New York, NY14.3MShares$702 Million0.07% of portfolio
-
Franklin Resources Inc San Mateo, CA14MShares$687 Million0.21% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $111B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...